The encapsulated payloads were effectively internalized and released into uPAR-positive breast and pancreatic cancer cells, following receptor-mediated endocytosis, and produced significant cytotoxic effects compared to equivalent concentrations of free drugs and non-targeted drug-loaded IONPs. Here, PLAUR is linked to familial pancreatic carcinoma.